Canada Life’s Alaunos Therapeutics TCRT Stock Holding History

Canada Life’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-75	Closed	-$8K	–	2463
2022 Q1	$8K	Hold	75	–	–	﹤0.01%	2453
2021 Q4	$12K	Hold	75	–	–	﹤0.01%	2434
2021 Q3	$21K	Hold	75	–	–	﹤0.01%	2428
2021 Q2	$30K	Hold	75	–	–	﹤0.01%	2409
2021 Q1	$40K	Hold	75	–	–	﹤0.01%	2361
2020 Q4	$28K	Hold	75	–	–	﹤0.01%	2481
2020 Q3	$28K	Hold	75	–	–	﹤0.01%	2347
2020 Q2	$37K	Buy	75 +14	+23%	+$6.24K	﹤0.01%	2331
2020 Q1	$23K	Hold	61	–	–	﹤0.01%	2347
2019 Q4	$43K	Buy	+61	New	+$42K	﹤0.01%	2315
2019 Q3	–	Sell	-118	Closed	-$103K	–	2149
2019 Q2	$103K	Hold	118	–	–	﹤0.01%	2220
2019 Q1	$68K	Hold	118	–	–	﹤0.01%	2187
2018 Q4	$32K	Hold	118	–	–	﹤0.01%	2483
2018 Q3	$56K	Hold	118	–	–	﹤0.01%	2366
2018 Q2	$53K	Hold	118	–	–	﹤0.01%	2390
2018 Q1	$69K	Hold	118	–	–	﹤0.01%	2287
2017 Q4	$73K	Hold	118	–	–	﹤0.01%	2265
2017 Q3	$109K	Hold	118	–	–	﹤0.01%	2125
2017 Q2	$109K	Hold	118	–	–	﹤0.01%	2091
2017 Q1	$111K	Hold	118	–	–	﹤0.01%	2086
2016 Q4	$95K	Hold	118	–	–	﹤0.01%	2129
2016 Q3	$99K	Hold	118	–	–	﹤0.01%	2141
2016 Q2	$96K	Hold	118	–	–	﹤0.01%	2114
2016 Q1	$131K	Hold	118	–	–	﹤0.01%	1596
2015 Q4	$147K	Buy	118 +71	+151%	+$117K	﹤0.01%	1482
2015 Q3	$64K	Hold	47	–	–	﹤0.01%	1980
2015 Q2	$85K	Buy	47 +4	+9%	+$6.21K	﹤0.01%	1975
2015 Q1	$69K	Buy	+43	New	+$63.7K	﹤0.01%	1991

Other funds holding TCRT

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Canada Life's TCRT Position: Q2 2022 in Review

Canada Life sold out of Alaunos Therapeutics (TCRT) in Q2 2022, closing a stake of 75 shares — an estimated $8K sold.

Canada Life first reported a position in TCRT in Q1 2015 and held it in 28 quarters. The position peaked at $147K in Q4 2015. 124 funds tracked by Wall St. Rank hold TCRT as of Q2 2022.

Canada Life reported no remaining Alaunos Therapeutics position as of Q2 2022 after selling out during the quarter.
Canada Life sold 75 Alaunos Therapeutics shares in Q2 2022, an estimated $8K.
Canada Life first reported a position in Alaunos Therapeutics in Q1 2015 and held it in 28 quarters.
Canada Life's Alaunos Therapeutics position peaked at $147K in Q4 2015.
124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2022.

Based on Canada Life's 13F filing for Q2 2022, filed 9 Aug 2022.